Stem cells for the ischaemic heart

Bibliography

• URBANEK K, QUAINI F, TASCA G et al.: From the cover: Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. USA (2003) 100(18):10440-10445.
   PubMed Web of Science ®Google Scholar
• MESSINA E, DE ANGELIS L, FRATI G et al.: Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. (2004) 95(9):911-921.
   PubMed Web of Science ®Google Scholar
• MURRY CE, SOONPAA MH, REINECKE H et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 328:664-668.
   Web of Science ®Google Scholar
• BALSAM LB, WAGERS AJ, CHRISTENSEN JL et al.: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 428:668-673.
   PubMed Web of Science ®Google Scholar
• CHIEN KR: Stem cells: lost in translation. Nature (2004) 428:607-608.
   PubMed Web of Science ®Google Scholar
• KAJSTURA J, ROTA M, WHANG B et al.: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. (2005) 96(1):127-137.
   PubMed Web of Science ®Google Scholar
• QUAINI F, URBANEK K, BELTRAMI AP et al.: Chimerism of the transplanted heart. N. Engl. J. Med. (2002) 346(1):5-15.
   PubMed Web of Science ®Google Scholar
• JIANG Y, JAHAGIRDAR BN, REINHARDT RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 418:41-49.
   PubMed Web of Science ®Google Scholar
• PITTENGER MF, MACKAY AM, BECK SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284:143-147.
   PubMed Web of Science ®Google Scholar
• ASAHARA T, MUROHARA T, SULLIVAN A et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 275:964-967.
   PubMed Web of Science ®Google Scholar
• GOLDSCHMIDT-CLERMONT PJ, PETERSON ED: On the memory of a chronic illness. Science’s SAGE KE (Science of Aging Knowledge Environment) (2003):12 November 2003.
   Google Scholar
• RAUSCHER FM, GOLDSCHMIDT-CLERMONT PJ, DAVIS BH et al.: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation (2003) 108:457-463.
   PubMed Web of Science ®Google Scholar
• SUZUKI T, NISHIDA M, FUTAMI S et al.: Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim. Cardiovasc. Res. (2003) 58:487-492.
   PubMed Web of Science ®Google Scholar
• FRAZIER OH, BALDWIN RT, ESKIN SG, DUNCAN JM: Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex. Heart Inst. J. (1993) 20:78-82.
   PubMed Web of Science ®Google Scholar
• RAFII S, OZ MC, SELDOMRIDGE A et al.: Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. (1995) 60:1627-1632.
   PubMed Web of Science ®Google Scholar
• SHI Q, RAFII S, WU MH et al.: Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 92(2):362-367.
   PubMed Web of Science ®Google Scholar
• KUNZ GA, LIANG G, CUCULOSKI F et al.: Circulating endothelial progenitor cells predict coronary artery disease severity. American College of Cardiology Annual Scientific Sessions. New Orleans, LA, USA (7 – 10 March 2004).
   Google Scholar
• EIZAWA T, IKEDA U, MURAKAMI Y et al.: Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart (2004) 90:685-686.
   PubMed Web of Science ®Google Scholar
• HILL JM, ZALOS G, HALCOX JPJ et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. (2003) 348:593-600.
   PubMed Web of Science ®Google Scholar
• VASA M, FICHTLSCHERER S, AICHER A et al.: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. (2001) 89:e1-e7.
   PubMed Web of Science ®Google Scholar
• TEPPER OM, GALIANO RD, CAPLA JM et al.: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation (2002) 106:2781-2786.
   PubMed Web of Science ®Google Scholar
• FADINI GP, MIORIN M, FACCO M et al.: Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. (2005) 45(9):1449-1457.
   PubMed Web of Science ®Google Scholar
• WANG X, ZHU J, CHEN J, SHANG Y: Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J. Clin. Pharmacol. (2004) 44(8):881-889.
   PubMed Web of Science ®Google Scholar
• KONDO T, HAYASHI M, TAKESHITA K et al.: Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol. (2004) 24(8):1442-1447.
   PubMed Web of Science ®Google Scholar
• HERBRIG K, PISTROSCH F, OELSCHLAEGEL U et al.: Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am. J. Kidney Dis. (2004) 44(5):840-849.
   PubMed Web of Science ®Google Scholar
• CHOI JH, KIM KL, HUH W et al.: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol. (2004) 24:1246-1252.
   PubMed Web of Science ®Google Scholar
• DE GROOT K, BAHLMANN FH, BAHLMANN E et al.: Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation (2005) 79(8):941-945.
   PubMed Web of Science ®Google Scholar
• VALGIMIGLI M, RIGOLIN GM, FUCILI A et al.: CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation (2004) 110(10):1209-1212.
   PubMed Web of Science ®Google Scholar
• LAMBIASE PD, EDWARDS RJ, ANTHOPOULOS P et al.: Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation (2004) 109(24):2986-2992.
   PubMed Web of Science ®Google Scholar
• GEORGE J, GOLDSTEIN E, ABASHIDZE S et al.: Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J. (2004) 25(12):1003-1008.
   PubMed Web of Science ®Google Scholar
• SKOWASCH D, JABS A, ANDRIE R et al.: Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc. Res. (2003) 60:684-691.
   PubMed Web of Science ®Google Scholar
• GEORGE J, HERZ I, GOLDSTEIN E et al.: Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol. (2003) 23:e57-e60.
   PubMed Web of Science ®Google Scholar
• LAUFS U, WERNER N, LINK A et al.: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation (2004) 109:220-226.
   PubMed Web of Science ®Google Scholar
• REHMAN J, LI J, PARVATHANENI L et al.: Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J. Am. Coll. Cardiol. (2004) 43(12):2314-2318.
   PubMed Web of Science ®Google Scholar
• SCHEUBEL RJ, ZORN H, SILBER RE et al.: Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. (2003) 42(12):2073-2080.
   PubMed Web of Science ®Google Scholar
• HEISS C, KEYMEL S, NIESLER U et al.: Impaired progenitor cell activity in age-related endothelial dysfunction. J. Am. Coll. Cardiol. (2005) 45(9):1441-1448.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO K, KONDO T, SUZUKI S et al.: Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler. Thromb. Vasc. Biol. (2004) 24(12):e192-e196.
   PubMed Web of Science ®Google Scholar
• HERBRIG K, HAENSEL S, OELSCHLAEGEL U et al.: Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann. Rheum. Dis. (2005) 65(2):157-163.
   PubMedGoogle Scholar
• GRISAR J, ALETAHA D, STEINER CW et al.: Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation (2005) 111(2):204-211.
   PubMed Web of Science ®Google Scholar
• SCHMIDT-LUCKE C, ROSSIG L, FICHTLSCHERER S et al.: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 111(22):2981-2987.
   PubMed Web of Science ®Google Scholar
• WERNER N, KOSIOL S, SCHIEGL T et al.: Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. (2005) 353(10):999-1007.
   PubMed Web of Science ®Google Scholar
• YOON YS, PARK JS, TKEBUCHAVA T, LUEDEMAN C, LOSORDO DW: Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation (2004) 109:3154-3157.
   PubMed Web of Science ®Google Scholar
• BEL A, MESSAS E, AGBULUT O et al.: Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation (2003) 108(Suppl. 1):II247-II252.
   PubMedGoogle Scholar
• DETEN A, VOLZ HC, CLAMORS S et al.: Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc. Res. (2005) 65(1):52-63.
   PubMed Web of Science ®Google Scholar
• ROOKMAAKER MB, VERHAAR MC, LOOMANS CJ et al.: CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrix. Arterioscler. Thromb. Vasc. Biol. (2005) 25(9):1843-1850.
   PubMed Web of Science ®Google Scholar
• YOON CH, HUR J, PARK KW et al.: Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation (2005) 112(11):1618-1627.
   PubMed Web of Science ®Google Scholar
• VENEZIA TA, MERCHANT AA, RAMOS CA et al.: Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. (2004) 2(10):e301.
   PubMed Web of Science ®Google Scholar
• MILLER JS, MCCULLAR V, PUNZEL M, LEMISCHKA IR, MOORE KA: Single adult human CD34+/Lin-/CD38- progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood (1999) 93(1):96-106.
   PubMed Web of Science ®Google Scholar
• ZEIGLER F, BENNETT B, JORDAN C et al.: Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood (1994) 84(8):2422-2430.
   PubMed Web of Science ®Google Scholar
• CHOI K, KENNEDY M, KAZAROV A, PAPADIMITRIOU J, KELLER G: A common precursor for hematopoietic and endothelial cells. Development (1998) 125(4):725-732.
   PubMed Web of Science ®Google Scholar
• GORDON PR, LEIMIG T, BAVARIN-DORNER A et al.: Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant. (2003) 31:17-22.
   PubMed Web of Science ®Google Scholar
• GEHLING UM, ERGUN S, SCHUMACHER U et al.: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood (2000) 95:3106-3112.
   PubMed Web of Science ®Google Scholar
• QUIRCI N, SOLIGO D, CANEVA L et al.: Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br. J. Haematol. (2001) 115:186-194.
   PubMed Web of Science ®Google Scholar
• TEPPER OM, CAPLA JM, GALIANO RD et al.: Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood (2005) 105(3):1068-1077.
   PubMed Web of Science ®Google Scholar
• KONG D, MELO LG, GNECCHI M et al.: Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation (2004) 110(14):2039-2046.
   PubMed Web of Science ®Google Scholar
• II M, NISHIMURA H, IWAKURA A et al.: Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via ‘imported’ nitric oxide synthase activity. Circulation (2005) 111(9):1114-1120.
   PubMed Web of Science ®Google Scholar
• KAWAMOTO A, GWON HC, IWAGURO H et al.: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation (2001) 103:634-637.
   PubMed Web of Science ®Google Scholar
• KAWAMOTO A, TKEBUCHAVA T, YAMAGUCHI JI et al.: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation (2003) 107:461-468.
   PubMed Web of Science ®Google Scholar
• KALKA C, MASUDA H, TAKAHASHI T et al.: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA (2000) 97:3422-3427.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI T, KALKA C, MASUDA H et al.: Ischemia-, and cytokine-induced mobilization of bone marrow-derived endothelial cell progenitor cells for neovascularization. Nat. Med. (1999) 5:434-438.
   PubMed Web of Science ®Google Scholar
• IWAGURO H, YAMAGUCHI JI, KALKA C et al.: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation (2002) 105(6):732-738.
   PubMed Web of Science ®Google Scholar
• GULATI R, SIMARI RD: Cell therapy for angiogenesis: embracing diversity. Circulation (2005) 112(11):1522-1524.
   PubMed Web of Science ®Google Scholar
• TOMA C, PITTENGER MF, CAHILL KS, BYRNE BJ, KESSLER PD: Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 105:93-98.
   PubMed Web of Science ®Google Scholar
• AMADO LC, SALIARIS AP, SCHULERI KH et al.: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA (2005) 102(32):11474-11479.
   PubMed Web of Science ®Google Scholar
• KAWADA H, FUJITA J, KINJO K et al.: Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood (2004) 104(12):3581-3587.
   PubMed Web of Science ®Google Scholar
• PITTENGER MF, MACKAY AM, BECK SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284(5411):143-147.
   PubMed Web of Science ®Google Scholar
• PITTENGER MF, MARTIN BJ: Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. (2004) 95(1):9-20.
   PubMed Web of Science ®Google Scholar
• LAW P: First human heart myoblast allograft. Circulation (2004) 110(Suppl. III):39.
   Web of Science ®Google Scholar
• MENASCHE P, HAGEGE AA, VILQUIN JT et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Card. (2003) 41(7):1078-1083.
   PubMed Web of Science ®Google Scholar
• ABRAHAM MR, HENRIKSON CA, TUNG L et al.: Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. (2005) 97(2):159-167.
   PubMed Web of Science ®Google Scholar
• REYES M, LUND T, LENVIK T et al.: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood (2001) 98(9):2615-2625.
   PubMed Web of Science ®Google Scholar
• OH H, BRADFUTE SB, GALLARDO TD et al.: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA (2003) 100(21):12313-12318.
   PubMed Web of Science ®Google Scholar
• URBANEK K, TORELLA D, SHEIKH F et al.: Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA (2005) 102(24):8692-8697.
   PubMed Web of Science ®Google Scholar
• KEHAT I, KENYAGIN-KARSENTI D, SNIR M et al.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. (2001) 108(3):407-414.
   PubMed Web of Science ®Google Scholar
• XIAO YF, MIN JY, MORGAN JP: Immunosuppression and xenotransplantation of cells for cardiac repair. Ann. Thorac. Surg. (2004) 77:737-744.
   PubMed Web of Science ®Google Scholar
• ZHANG YM, HARTZELL C, NARLOW M, DUDLEY SC: Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation (2002) 106:1294-1299.
   PubMed Web of Science ®Google Scholar
• ORLIC D, KAJSTURA J, CHIMENTI S et al.: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA (2001) 98(18):10344-10349.
   PubMed Web of Science ®Google Scholar
• KANG HJ, KIM HS, ZHANG SY et al.: Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet (2004) 363:751-756.
   PubMed Web of Science ®Google Scholar
• INCE H, PETZSCH M, KLEINE HD et al.: Prevention of LV remodeling with G-CSF in acute myocardial infarction: insights from FIRSTLINE-AMI (Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor). Circulation (2004) 110(Suppl. III):352.
   Google Scholar
• VIJ R, ADKINS DR, BROWN RA, KHOURY H, DIPERSIO JF: Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony stimulating factor. Transfusion (1999) 39:542-543.
   PubMed Web of Science ®Google Scholar
• MATSUBARA H: Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy. Lancet (2004) 363(9411):746-747.
   PubMed Web of Science ®Google Scholar
• FUKUMOTO Y, MIYAMOTO T, OKAMURA T et al.: Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br. J. Haematol. (1997) 97:666-668.
   PubMed Web of Science ®Google Scholar
• DOBERT N, BRITTEN M, ASSMUS B et al.: Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur. J. Nucl. Med. Mol. Imaging (2004) 31(8):1146-1151.
   PubMed Web of Science ®Google Scholar
• ASSMUS B, SCHACHINGER V, TEUPE C et al.: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 106:3009-3017.
   PubMed Web of Science ®Google Scholar
• VANDERHEYDEN M, MANSOUR S, BARTUNEK J: Accelerated atherosclerosis following intracoronary haematopoietic stem cell administration. Heart (2005) 91(4):448.
   PubMedGoogle Scholar
• STAMM C, WESTPHAL B, KLEINE HD et al.: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet (2003) 361:45-46.
   PubMed Web of Science ®Google Scholar
• WOLLERT KC, MEYER GP, LOTZ J et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 364:141-148.
   PubMed Web of Science ®Google Scholar
• STRAUER BE, BREHM M, ZEUS T et al.: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 106:1913-1918.
   PubMed Web of Science ®Google Scholar
• BRITTEN M, ABOLMAALI ND, ASSMUS B et al.: Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Circulation (2003) 108:2212-2218.
   PubMed Web of Science ®Google Scholar
• SCHACHINGER V, ASSMUS B, BRITTEN MB et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J. Am. Coll. Cardiol. (2004) 44(8):1690-1699.
   PubMed Web of Science ®Google Scholar
• HOCHT-ZEISBERG E, KAHNERT H, GUAN K et al.: Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur. Heart J. (2004) 25(9):749-758.
   PubMed Web of Science ®Google Scholar
• GLASER R, LU MM, NARULA N, EPSTEIN JA: Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation (2002) 106:17-19.
   PubMed Web of Science ®Google Scholar
• LAFLAMME MA, MYERSON D, SAFFITZ JE, MURRY CE: Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. (2002) 90:634-640.
   PubMed Web of Science ®Google Scholar
• ORLIC D, KAJSTURA J, CHIMENTI S et al.: Bone marrow cells regenerate infarcted myocardium. Nature (2001) 410:701-705.
   PubMed Web of Science ®Google Scholar
• BADORFF C, BRANDES RP, POPP R et al.: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation (2003) 107(7):1024-1032.
   PubMed Web of Science ®Google Scholar
• NYGREN JM, JOVINGE S, BREITBACH M et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. (2004) 10(5):494-501.
   PubMed Web of Science ®Google Scholar
• ALVAREZ-DOLADO M, PARDAL R, GARCIA-VERDUGO JM et al.: Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocyes. Nature (2003) 425(6961):968-973.
   PubMed Web of Science ®Google Scholar
• MULLER P, PFEIFFER P, KOGLIN J et al.: Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation (2002) 106:31-35.
   PubMed Web of Science ®Google Scholar
• LAPIDOS KA, CHEN YE, EARLEY JU et al.: Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J. Clin. Invest. (2004) 114(11):1577-1585.
   PubMed Web of Science ®Google Scholar
• GRIESE DP, AHSAN A, MELO LG et al.: Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation (2003) 108:2710-2715.
   PubMed Web of Science ®Google Scholar
• GULATI R, JEVREMOVIC D, PETERSON TE et al.: Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. (2003) 93:1023-1025.
   PubMed Web of Science ®Google Scholar
• JACKSON KA, MAJKA SM, WANG H et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. (2001) 107:1395-1402.
   PubMed Web of Science ®Google Scholar
• WANG C, JIAO C, HANLON HD et al.: Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors. Am. J. Physiol. Heart Circ. Physiol. (2004) 86(5):H1985-H1993.
   Google Scholar
• MANGI AA, NOISEUX N, KONG D et al.: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. (2003) 9(9):1195-1201.
   PubMed Web of Science ®Google Scholar
• GNECCHI M, HE H, LIANG OD et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. (2005) 11(4):367-368.
   PubMed Web of Science ®Google Scholar
• GULATI R, JEVREMOVIC D, PETERSON TE et al.: Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation (2003) 108(12):1520-1526.
   PubMed Web of Science ®Google Scholar
• JAQUET K, KRAUSE KT, DENSCHEL J et al.: Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev. (2005) 14(3):299-309.
   PubMed Web of Science ®Google Scholar
• AICHER A, BRENNER W, ZUHAYRA M et al.: Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation (2003) 107:2134-2139.
   PubMed Web of Science ®Google Scholar
• BARBASH IM, CHOURAQUI P, BARON J et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 108(7):863-868.
   PubMed Web of Science ®Google Scholar
• CHIN BB, NAKAMOTO Y, BULTE JW et al.: 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl. Med. Commun. (2003) 24(11):1149-1154.
   PubMed Web of Science ®Google Scholar
• FRANGIONI JV, HAJJAR RJ: In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation (2004) 110(21):3378-3383.
   PubMed Web of Science ®Google Scholar
• KRAITCHMAN DL, TATSUMI M, GILSON WD et al.: Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 112(10):1451-1461.
   PubMed Web of Science ®Google Scholar
• MA J, GE J, ZHANG S et al.: Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res. Cardiol. (2005) 100(3):217-223.
   PubMed Web of Science ®Google Scholar
• KUETHE F, RICHARTZ BM, SAYER HG et al.: Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int. J. Cardiol. (2004) 97(1):123-127.
   PubMed Web of Science ®Google Scholar
• JANSSENS S, DUBOIS C, BOGAERT J et al.: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet (2006) 367(9505):113-121.
   PubMed Web of Science ®Google Scholar
• LUNDE K: Effects on left ventricular function by intracoronary injections of autologous mononuclear bone marrow cells in acute anterior wall myocardial infarction: the ASTAMI randomized controlled trial. American Heart Association Scientific Sessions. Dallas, TX, USA (13 – 16 November 2005).
   Google Scholar
• SCHACHINGER V: Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo-controlled multicenter trial (REPAIR-AMI). American Heart Association Scientific Sessions. Dallas, TX, USA (13 – 16 November 2005).
   Google Scholar
• CHEN SL, FANG WW, YE F et al.: Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. (2004) 94(1):92-95.
   PubMed Web of Science ®Google Scholar
• VUILLIET PR, GREELEY M, HALLORAN SM, MACDONALD KA, KITTLESON MD: Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet (2004) 363:783-784.
   PubMed Web of Science ®Google Scholar
• MEYER GP, WOLLERT KC, LOTZ J et al.: Bone marrow transfer to enhance ST-elevation infarct regeneration: long-term magnetic resonance imaging data from the BOOST trial. American Heart Association Scientific Sessions. New Orleans, LA, USA (7 – 10 November 2004).
   Google Scholar
• PETZSCH M, INCE H, KLEINE H et al.: No restenosis after G-CSF in acute myocardial infarction: insights from FIRSTLINE-AMI (Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor). Circulation (2004) 110(Suppl. III):238.
   Google Scholar
• INCE H, PETZSCH M, KLEINE HD et al.: Preservation from left ventricular remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony-Stimulating Factor (FIRSTLINE-AMI). Circulation (2005) 112(20):3097-3106.
   PubMed Web of Science ®Google Scholar
• ZOHLNHOFER D, OTT I, MEHILLI J et al.: Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. REVIVAL-2 Investigators. JAMA (2006) 295(9):1003-1010.
   PubMed Web of Science ®Google Scholar
• HILL JM, SYED MA, ARAI AE et al.: Outcomes and Risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. (2005) 46(9):1643-1648.
   PubMed Web of Science ®Google Scholar
• PERIN EC, DOHMANN HF, BOROJEVIC R et al.: Transendocardial, autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation (2003) 107:2294-2302.
   PubMed Web of Science ®Google Scholar
• FUCHS S, SATLER LF, KORNOWSKI R et al.: Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. J. Am. Coll. Cardiol. (2003) 41:1721-1724.
   PubMed Web of Science ®Google Scholar
• TSE HF, KWONG YL, CHAN JK et al.: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell transplantation. Lancet (2003) 361:47-49.
   PubMed Web of Science ®Google Scholar
• GALINANES M, LOUBANI M, DAVIES J et al.: Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. (2004) 13(1):7-13.
   PubMed Web of Science ®Google Scholar
• HAMANO K, NISHIDA M, HIRATA K et al.: Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease. Jpn. Circ. J. (2001) 65:845-847.
   PubMedGoogle Scholar
• ASSMUS B, HONOLD J, LEHMANN R et al.: Transcoronary transplantation of progenitor cells and recovery of left ventricular function in patients with chronic ischemic heart disease: results of a randomized, controlled trial. Circulation (2004) 110(Suppl. III):238.
   Google Scholar
• STRAUER BE, BREHM M, ZEUS T et al.: Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J. Am. Coll. Cardiol. (2005) 46(9):1651-1658.
   PubMed Web of Science ®Google Scholar
• SMITS PC, VAN GEUNS RJ, POLDERMANS D et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. (2003) 42(12):2063-2069.
   PubMed Web of Science ®Google Scholar
• CHACHQUES JC, HERREROS J, TRAININI J et al.: Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol. (2004) 95(Suppl. 1):S29-S33.
   PubMed Web of Science ®Google Scholar
• SIMINIAK T, KALAWSKI R, FISZER D et al.: Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. (2004) 148(3):531-537.
   PubMed Web of Science ®Google Scholar
• HERREROS J, PROSPER F, PEREZ A et al.: Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. (2003) 24(22):2012-2020.
   PubMed Web of Science ®Google Scholar
• OZBARAN M, OMAY SB, NALBANTGIL S et al.: Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur. J. Cardiothoracic. Surg. (2004) 25:342-351.
   PubMed Web of Science ®Google Scholar
• LE BLANC K, RINGDEN O: Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. (2005) 11(5):321-334.
   PubMed Web of Science ®Google Scholar
• SHINTANI S, MUROHARA T, IKEDA H et al.: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 103:276-2779.
   PubMed Web of Science ®Google Scholar
• HEESCHEN C, LEHMANN R, HONOLD J et al.: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation (2004) 109:1615-1622.
   PubMed Web of Science ®Google Scholar
• CELLETTI FL, WAUGH JM, AMABILE PG et al.: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. (2001) 7(4):425-429.
   PubMed Web of Science ®Google Scholar
• MOULTON KS, VAKILI K, ZURAKOWSKI D et al.: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA (2003) 100(8):4736-4741.
   PubMed Web of Science ®Google Scholar